Efficacy and Safety Results of the Afatinib Expanded Access Program
Kim, Edward S., Halmos, Balazs, Kohut, Ingrid F., Patel, Taral, Rostorfer, Regan D., Spira, Alexander I., Cseh, Agnieszka, McKay, John, Wallenstein, Gudrun, Mileham, Kathryn F.
Published in Oncology and therapy (01.06.2017)
Published in Oncology and therapy (01.06.2017)
Get full text
Journal Article
Potent Cell-Cycle Inhibition and Upregulation of Immune Response with Abemaciclib and Anastrozole in neoMONARCH, Phase II Neoadjuvant Study in HR + /HER2 - Breast Cancer
Hurvitz, Sara A, Martin, Miguel, Press, Michael F, Chan, David, Fernandez-Abad, María, Petru, Edgar, Rostorfer, Regan, Guarneri, Valentina, Huang, Chiun-Sheng, Barriga, Susana, Wijayawardana, Sameera, Brahmachary, Manisha, Ebert, Philip J, Hossain, Anwar, Liu, Jiangang, Abel, Adam, Aggarwal, Amit, Jansen, Valerie M, Slamon, Dennis J
Published in Clinical cancer research (01.02.2020)
Published in Clinical cancer research (01.02.2020)
Get full text
Journal Article
Abstract PS10-42: Clinical outcomes with neoadjuvant chemotherapy plus dual anti-HER2 therapy in patients with operable/locally advanced breast cancer: Single institution experience
Shah, Nirja, Shah, Nikita, Baidas, Said, Cuesta-Fernandez, Ana, Demers, Marc, Demori, Maria, Dvorak, Tomas, Eisenberg, Rachel, Gross, Terrence, Henry, Danielle, Kahky, Michael, Kelly, Patrick, Kolli, Swathy, Rostorfer, Regan, Smith, Jeffrey, Swanick, Cameron, Mamounas, Eleftherios
Published in Cancer research (Chicago, Ill.) (15.02.2021)
Published in Cancer research (Chicago, Ill.) (15.02.2021)
Get full text
Journal Article